![](https://wimg.heraldcorp.com/news/cms/2025/02/05/news-p.v1.20250205.01c51b9659134b85b1f92ae864bd7685_T1.jpg)
Celltrion’s Vegzelma becomes Europe’s top prescribed bevacizumab
Celltrion announced Wednesday that its metastatic colorectal and breast cancer drug, Vegzelma, has become the most prescribed bevacizumab in Europe, demonstrating strong growth in its market share. According to market research firm IQVIA, Vegzelma …